FDA Brief

Warning letters Food

FDA warning letter to

ICA Health, LLC/Future Formulations, LLC

MediumIssued Sep 20, 2021Posted Oct 5, 2021Office of Human and Animal Foods Operations – Division West 4

ICA Health sells five Dr. Wilson supplements with website claims that make them unapproved new drugs, FDA says.

What happened

FDA reviewed three websites (www.icahealth.com, www.drwilsons.com, www.adrenalfatigue.org) in July 2021 and found the firm takes orders there for five Dr. Wilson's supplements. The sites described the products as helping with diabetes, blood sugar problems, colds and flu, herpes outbreaks, depression, rheumatoid arthritis and other diseases, which FDA says shows the products are intended as drugs. FDA also says four of the products lack adequate directions for use and are therefore misbranded.

What FDA found

  1. Website claims that the supplements treat or prevent diseases such as diabetes, colds and flu, herpes and depression make the products drugs in FDA's view.

    section 201(g)(1)(B) of the Act [21 U.S.C. 321(g)(1)(B)]
  2. Because the products are not generally recognized as safe and effective for those uses and FDA has not approved them, they are unapproved new drugs and cannot be sold across state lines.

    sections 201(p), 301(d) and 505(a) of the Act [21 U.S.C. 321(p), 331(d), 355(a)]
  3. Good Sugar, Cortisol Stress Reset, BFF and Nat-Stim are meant for diseases a layperson cannot safely diagnose or treat alone, so they cannot carry adequate directions for use and are misbranded.

    section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)]; 21 CFR 201.5
  4. Shipping these misbranded drugs across state lines violates the Act.

    section 301(a) of the Act [21 U.S.C. 331(a)]

What FDA wants

FDA asks the company to write back within 15 working days of receiving the letter describing the specific steps taken to fix the violations and prevent them from recurring, with supporting documents. If the work is not finished in that time, the company must explain why and say when it will be done.

Who should pay attention

  • supplement brands whose websites carry disease-treatment or symptom-relief claims
  • retailers and distributors selling Dr. Wilson's branded supplements
  • regulatory reviewers who check website and marketing copy for drug claims

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk